TELIGEN
Report
- Report Number
- 2124215-2011-00362
- Event Type
- Injury
- Date Received
- April 5, 2011
- Date of Event
- October 28, 2010
- Report Date
- January 4, 2011
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
ALL AVAILABLE INFORMATION INDICATES THAT THE DEVICE REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
DEFIBRILLATION THRESHOLD TESTING WAS PERFORMED, RESULTING IN SHOCK IMPEDANCE MEASUREMENTS WITHIN NORMAL LIMITS. THE PATIENT'S PHYSICIAN WAS AWARE OF THE OUT OF RANGE IMPEDANCE MEASUREMENT AND HAD NOT ELECTED FOR FURTHER INTERVENTION AT THIS TIME.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT VARYING SHOCK IMPEDANCE MEASUREMENTS WERE DETECTED ON THIS DEVICE SYSTEM. THE MEASUREMENTS REMAINED WITHIN ACCEPTABLE LIMITS. APPROXIMATELY TWO MONTHS LATER, A SHOCK IMPEDANCE MEASUREMENT GREATER THAN 125 OHMS WAS OBSERVED. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED FOR THIS CLINICAL OBSERVATION.
--
--
ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT IMPLANTED WITH THIS DEVICE SYSTEM WAS TO BE BROUGHT INTO THE CLINIC FOR DEFIBRILLATION THRESHOLD TESTING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E102 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Life Threatening| R | 0147| T135| E102 |